Extracorporeal Membrane Oxygenation for Pediatric Patients With Coronavirus Disease 2019-Related Illness

Robert M MacGregor1, Ryan M Antiel1, Tasnim Najaf2

  • 1Division of Pediatric Surgery, Department of Surgery, Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, MO.

Insights

Pediatric extracorporeal membrane oxygenation (ECMO) centers have established guidelines for COVID-19 patients, with most treating pediatric cases similarly to other viral illnesses. Further research is needed on resource allocation and extracorporeal cardiopulmonary resuscitation (ECPR) use.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Medical ethics

Background:

  • Coronavirus disease 2019 (COVID-19) presented unique challenges for pediatric intensive care.
  • Extracorporeal membrane oxygenation (ECMO) is a vital life support measure for critically ill patients.
  • Guidelines for ECMO use in pediatric COVID-19 patients were rapidly evolving in early 2020.

Purpose of the Study:

  • To survey U.S. children's hospitals regarding their ECMO guidelines for COVID-19 pediatric patients.
  • To ascertain ECMO leaders' opinions on ethical dilemmas related to pediatric COVID-19 care.
  • To understand current practices and inform future recommendations for ECMO in pediatric COVID-19.

Main Methods:

  • A confidential, self-administered questionnaire was distributed to 127 U.S. pediatric ECMO centers.
  • The survey collected data on existing hospital ECMO guidelines for COVID-19.
  • Respondents provided opinions on ethical issues: pediatric prioritization, do-not-resuscitate (DNR) orders, and extracorporeal cardiopulmonary resuscitation (ECPR).

Main Results:

  • 47 (37%) of centers had enacted specific ECMO guidelines for COVID-19.
  • Most centers (94%) applied similar ECMO indications as for other viral illnesses (e.g., RSV, influenza).
  • 98% of leaders opposed DNR orders for pediatric COVID-19 patients; 60% opposed ECPR for COVID-19.

Conclusions:

  • The majority of pediatric ECMO centers developed guidelines for COVID-19.
  • There is consensus against DNR orders for pediatric COVID-19 patients.
  • Further guidance is required for equitable ECMO resource allocation and ECPR appropriateness in pediatric COVID-19.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
902
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
447
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
655
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
365
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
690
Oxygen Delivering System I: Nasal Cannula and Face Mask01:26

Oxygen Delivering System I: Nasal Cannula and Face Mask

The human body requires oxygen to function, and when the natural process of respiration is hindered, external devices, including the following, are needed to help deliver this vital gas.
Nasal Cannula
A nasal cannula is a lightweight tube split at one end into two prongs and placed in the nostrils. It is typically used to deliver low to medium levels of oxygen.
Suggested flow rate: The suggested flow rate for a nasal cannula typically ranges between 1 and 6 L/min.
Oxygen percentage setting:...
1.2K